Form 8.5 (EPT/RI) - Mediclinic Amendment

03/08/2022

RNS Number : 7973U
UBS AG (EPT)
03 August 2022
 

This announcement replaces the previous RNS announcement 6199U released at 10:50 on the 2nd August 2022. Amendments to sections 2a and 2b. All other information remains unchanged

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the Code)

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

            UBS Investment Bank, London

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

            Mediclinic International plc

(c) Name of the party to the offer with which exempt principal trader is connected:

            Mediclinic International plc

(d) Date dealing undertaken:

            01 August 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

     If it is a cash offer or possible cash offer, state "N/A"

NO

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Buy

 

527379

4.87801        GBP

4.75467        GBP

10p ordinary

Sell

 

608083

4.87801        GBP

4.74724        GBP

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

 

Long

1896

4.867439        GBP

10p ordinary

CFD

 

Long

41617

4.878        GBP

10p ordinary

CFD

 

Long

64997

97.10274536        ZAR

10p ordinary

CFD

 

Long

58591

97.22975175        ZAR

10p ordinary

CFD

 

Long

114077

97.19203639        ZAR

10p ordinary

CFD

 

Long

66619

4.875561        GBP

10p ordinary

CFD

 

Long

2544

4.860916        GBP

10p ordinary

CFD

 

Long

709

4.855433        GBP

10p ordinary

CFD

 

Long

2399

4.84198011        GBP

10p ordinary

CFD

 

Long

96197

4.827        GBP

10p ordinary

CFD

 

Long

4

4.834        GBP

10p ordinary

CFD

 

Long

34091

4.862843        GBP

10p ordinary

CFD

 

Long

576

4.854        GBP

10p ordinary

CFD

 

Short

96197

4.827        GBP

10p ordinary

CFD

 

Short

1746

4.77899397        GBP

10p ordinary

CFD

 

Short

15482

4.84992378        GBP

10p ordinary

CFD

 

Short

58591

97.22975175        ZAR

10p ordinary

CFD

 

Short

34318

97.1027147561047        ZAR

10p ordinary

CFD

 

Short

30679

97.1027795886437        ZAR

10p ordinary

CFD

 

Short

298

4.834054        GBP

10p ordinary

CFD

 

Short

114077

97.19203639        ZAR

10p ordinary

CFD

 

Short

3585

4.825077        GBP

10p ordinary

CFD

 

Short

7310

4.878        GBP

10p ordinary

CFD

 

Short

11571

4.875504        GBP

10p ordinary

CFD

 

Short

6188

4.845402        GBP

10p ordinary

CFD

 

Short

4098

4.871227        GBP

10p ordinary

CFD

 

Short

390

4.83669231 GBP

10p ordinary

CFD

 

Short

1140

4.83720175 GBP

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none "

 

None

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

03 August 2022

Contact name:

Richard Howard

Telephone number:

+44 (0)207 568 9128

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERBKNBNKBKDPFK

Website Notice Block